ישראל - עברית - Ministry of Health

די.טי.י. מדיקל סופליי בע"מ - רופא - מצלמות אנדוסקופ - צילום ותיעוד בדיקות רפואיות

ישראל - עברית - Ministry of Health

די.טי.י. מדיקל סופליי בע"מ - רופא - ציוד דיאגנוסטי לבדיקות עיניים אוזניים אף אוזן גרון

ישראל - עברית - Ministry of Health

די.טי.י. מדיקל סופליי בע"מ - רופא - אבחון תפקודי לב

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - sumatriptan as succinate 50 mg - tablets fast disintegrating - sumatriptan - acute relief of migraine attacks with or without aura. for the acute treatment of migraine attacks associated with women's menstrual cycle.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - sumatriptan as succinate 100 mg - tablets fast disintegrating - sumatriptan - acute relief of migraine attacks with or without aura. for the acute treatment of migraine attacks associated with women's menstrual cycle.

ישראל - עברית - Ministry of Health

isorad ltd, israel - calcium trisodium pentetate - תמיסה להזרקה - calcium trisodium pentetate 20 mg/vial - technetium (99mtc) pentetic acid - technetium (99mtc) pentetic acid - kidney, brain, aerosol imaging.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - rimegepant as sulfate - rimegepant as sulfate 75 mg

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 1 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 2 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - eptacog alfa (activated) - אבקה להכנת תמיסה לזריקה - eptacog alfa (activated) 5 mg/vial - eptacog alfa (activated) - eptacog alfa (activated) - treatment of bleeding episodes and prevention of bleeding in those undergoing surgery of invasive procedures in the following patient goups : * in patients with congenital haemophilia with inhibitors to coagulation factors viii or ix > 5 bu, * in patients with congenital haemophilia who are expected to have a high anamnestic response to factor viii or factor ix administration, * in patients with acquired haemophilia, in patients with congenital fvii deficieny, * in patients with glanzmann's thropnbastenia with antibodies to gp iib-iiia and/or hla, and with past or present refractoriness to platelet transfusions.